Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Control Trial of Unfractionated Heparin Thromboprophylaxis Dosing for Antepartum Hospitalizations

NCT04635839 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT04635839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04635839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Control Trial of Unfractionated Heparin Thromboprophylaxis Dosing for Antepartum Hospitalizations
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Completed
Start date
December 15, 2020
Completion date
May 1, 2022
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antepartum dvt, pregnancy related